Previous studies have unequivocally demonstrated that constitutive activation of MYB, or more rarely MYBL1, are key genomic events in the pathogenesis of ACC [9,11,14,15,17,18,19,20]. This evidence concerns the gene MYBL1 and adrenal cortex carcinoma.